4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-22-019949
Options or other derivatives
- Chief Commercial Officer acquired 368,734 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Habig Scott Michael Chief Commercial Officer | 2022-08-01 | Grant or award · Stock Option (right to buy) | +231,203 | 231,203 | D | ||
| Habig Scott Michael Chief Commercial Officer | 2022-08-01 | Grant or award · Restricted Stock Units | +137,531 | 137,531 | D | ||
Loading xslF345X03/wf-form4_165938478001230.xml…